Damora Therapeutics (DMRA) Earnings Date & Reports
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
DMRA is expected to report earnings to fall 29.63% to -43 cents per share on August 05
Q2'26
Est.
$-0.44
Q1'26
Missed
by $0.30
Q4'25
Missed
by $135.47
The last earnings report on May 12 showed earnings per share of -62 cents, missing the estimate of -31 cents. With 490.15K shares outstanding, the current market capitalization sits at 1.85B.